Methods to elicit, enhance and sustain immune responses against MHC class1 restricted epitopes, for prophylactic or therapeutic purposes

Details for Australian Patent Application No. 2007272785 (hide)

International Classifications

Event Publications

5 February 2009 PCT application entered the National Phase

PCT publication WO2008/008541 Priority application(s): WO2008/008541

11 June 2009 Amendment Made

The nature of the amendment is: Amend the inventor name from Bot, Adrian Ian to Bot, Adrian Ion

26 November 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name MannKind Corporation, Application No. 2007272785, under INID (54) correct the title to read Methods to elicit, enhance and sustain immune responses against MHC class-I restricted epitopes, for prophylactic or therapeutic purposes. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 200330011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.